Literature DB >> 8206645

Expression and secretion of active mouse TIMP-1 using a baculovirus expression vector.

E T Cocuzzi1, S E Walther, D T Denhardt.   

Abstract

Mouse TIMP-1, one of the tissue inhibitors of metalloproteinases important in regulating turnover of extracellular matrix in both normal and pathological tissues, was previously expressed in E. coli in an inactive, nonglycosylated state that required refolding to become functional. Due to the difficulty of renaturation, an alternative to the prokaryotic expression system was sought. Since we are interested in studying the pharmacodynamics and pharmacokinetics of TIMP locally administered by controlled delivery to mice with experimentally induced arthritis, we also needed an efficient way of producing active TIMP in large quantities. Using the pBlueBacII transfer vector, we generated a recombinant baculovirus that in Sf9 cells could express glycosylated mouse TIMP-1 to about 3 mg of active protein/liter conditioned medium.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8206645     DOI: 10.1007/bf01534596

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  15 in total

1.  Expression and purification of mouse TIMP-1 from E. coli.

Authors:  E T Cocuzzi; S E Walther; S Rajan; D T Denhardt
Journal:  FEBS Lett       Date:  1992-08-03       Impact factor: 4.124

2.  Role of the 21-kDa protein TIMP-3 in oncogenic transformation of cultured chicken embryo fibroblasts.

Authors:  T T Yang; S P Hawkes
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

3.  Refolding of recombinant proteins.

Authors:  T Kohno; D F Carmichael; A Sommer; R C Thompson
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

4.  Insertion mutagenesis to increase secondary structure within the 5' noncoding region of a eukaryotic mRNA reduces translational efficiency.

Authors:  J Pelletier; N Sonenberg
Journal:  Cell       Date:  1985-03       Impact factor: 41.582

5.  A growth-responsive gene (16C8) in normal mouse fibroblasts homologous to a human collagenase inhibitor with erythroid-potentiating activity: evidence for inducible and constitutive transcripts.

Authors:  D R Edwards; P Waterhouse; M L Holman; D T Denhardt
Journal:  Nucleic Acids Res       Date:  1986-11-25       Impact factor: 16.971

6.  Systemic administration of TIMP in the treatment of collagen-induced arthritis in mice.

Authors:  D F Carmichael; G P Stricklin; J M Stuart
Journal:  Agents Actions       Date:  1989-06

Review 7.  Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions.

Authors:  D T Denhardt; B Feng; D R Edwards; E T Cocuzzi; U M Malyankar
Journal:  Pharmacol Ther       Date:  1993-09       Impact factor: 12.310

8.  Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity.

Authors:  A J Docherty; A Lyons; B J Smith; E M Wright; P E Stephens; T J Harris; G Murphy; J J Reynolds
Journal:  Nature       Date:  1985 Nov 7-13       Impact factor: 49.962

9.  Site-directed mutations that alter the inhibitory activity of the tissue inhibitor of metalloproteinases-1: importance of the N-terminal region between cysteine 3 and cysteine 13.

Authors:  M O'Shea; F Willenbrock; R A Williamson; M I Cockett; R B Freedman; J J Reynolds; A J Docherty; G Murphy
Journal:  Biochemistry       Date:  1992-10-27       Impact factor: 3.162

10.  Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin.

Authors:  G I Goldberg; A Strongin; I E Collier; L T Genrich; B L Marmer
Journal:  J Biol Chem       Date:  1992-03-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.